Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Sep;47(9):315-9.

[Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency]

[Article in Italian]
Affiliations
  • PMID: 10630070
Clinical Trial

[Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency]

[Article in Italian]
G La Marca et al. Minerva Cardioangiol. 1999 Sep.

Abstract

Background: Aim of the present comparative clinical study was to demonstrate the efficacy of the topical application of mesoglycan, a profibrinolytic agent, for healing of leg ulcers in patients with chronic venous insufficiency.

Methods: Forty patients, observed in our outpatients department, with venous leg ulcers have been randomized in two groups of twenty subjects, each treated with topical application of mesoglycan (1 or 2 vials/day) or vegetal stimulins and followed for two months, with controls after 15, 30 and 60 days.

Results: At the end of the observation period, ulcer healing rate was 95% in the mesoglycan group, while a lower healing rate was obtained in the stimulins group (80%).

Conclusions: The present study confirms previous clinical experiences with mesoglycan and suggests its application in the topical treatment of venous ulcers.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources